Evidence map›Paper›PMID 25572448›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2015

Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs.

Yu Zhou, Li Sun, Xu Wang, Li Zhou, Jieliang Li, Manqing Liu, Fang Wang, Jinsong Peng, Xi'en Gui, Huaqing Zhao and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Biochemical Diagnosis in Substance and Non-substance Addiction.Advances in experimental medicine and biology · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Heroin Abuse and/or HIV Infection Dysregulate Plasma Exosomal miRNAs.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Yu ZhouDepartment of Pathology and Laboratory Medicine, Temple University School of Medicine, 3500 N. Broad St., Philadelphia, PA, 19140, USA.
Li Sun
Xu Wang
Li Zhou
Jieliang Li
Manqing Liu
Fang Wang
Jinsong Peng
Xi'en Gui
Huaqing Zhao
Nancy Reichenbach
Dunjin Zhou
Wen-Zhe Ho
Temple University · USWuhan Center for Disease Control and Prevention · CNWuhan University · CNClinical Research Institute · USZhongnan Hospital of Wuhan University · CN

Funding

Drug Abuse, Sustance P and HIVR01DA012815 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2000 to 2013
$4.5M
Opioids, HIV/HCV and Host Cell Innate ImmunityR01DA022177 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2007 to 2017
$2.9M
Opioids, LPS and HIVR01DA027550 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2010 to 2014
$1.4M
NIDA NIH HHS DA012815NIDA NIH HHS DA022177NIDA NIH HHS DA027550NIDA NIH HHS R01 DA012815NIDA NIH HHS R01 DA022177NIDA NIH HHS R01 DA027550
6 · The paper itself

Abstract

Hepatitis C virus (HCV) infection is common among injection drug users (IDUs). There is accumulating evidence that circulating microRNAs (miRNAs) are associated with HCV infection and disease progression. The present study was undertaken to determine the in vivo impact of heroin use on HCV infection and HCV-related circulating miRNA expression. Using the blood specimens from four groups of the study subjects (HCV-infected individuals, heroin users with/without HCV infection, and healthy volunteers), we found that HCV-infected heroin users had significantly higher viral load than HCV-infected non-heroin users (p = 0.0004). Measurement of HCV-related circulating miRNAs in plasma showed that miRs-122, 141, 29a, 29b, and 29c were significantly increased in the heroin users with HCV infection, whereas miR-351, an HCV inhibitory miRNA, was significantly decreased in heroin users as compared to control subjects. Further investigation identified a negative correlation between the plasma levels of miR-29 family members and severity of HCV infection based on aspartate aminotransferase to platelet ratio index (APRI). In addition, heroin use and/or HCV infection also dysregulated a panel of plasma miRNAs. Taken together, these data for the first time revealed in vivo evidence that heroin use and/or HCV infection alter circulating miRNAs, which provides a novel mechanism for the impaired innate anti-HCV immunity among IDUs.

Indexed as

AdultAspartate AminotransferasesFemaleGene Expression Regulation, ViralHepacivirusHepatitis CHeroin DependenceHumansMaleMicroRNAsMiddle AgedPlatelet CountRNA, ViralViral LoadAspartate AminotransferasesMicroRNAsRNA, Viral

Identifiers

PMID25572448
PMCPMC4444785
OpenAlexW1982326626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.